Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.95 USD | -0.25% | -2.24% | +73.02% |
Jun. 05 | Y-mAbs Therapeutics, Inc. Appoints Norman LaFrance as Chief Development Officer | CI |
Jun. 01 | Y-mAbs Therapeutics, Inc. Announces Publication of Preclinical GD2-SADA Data | CI |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.